The Year in Diabetes and Obesity
Seiten
2012
|
Volume 1243
Wiley-Blackwell (Verlag)
978-1-57331-847-1 (ISBN)
Wiley-Blackwell (Verlag)
978-1-57331-847-1 (ISBN)
Includes reviews on central nervous system control of glucose and energy metabolism; stearoyl CoA desaturase in obesity and metabolism; circadian disruption and metabolic dysfunction; incretin hormones; and, more.
This second installment of The Year in Diabetes and Obesity review series includes thought-provoking reviews on central nervous system control of glucose and energy metabolism; stearoyl CoA desaturase in obesity and metabolism; circadian disruption and metabolic dysfunction; incretin hormones; metabolic syndrome, adipokines, and dementia; interventions for the prevention or reversal of type 1 diabetes; the role of intestinal microbiome in humans and mice with type 1 diabetes; building smarter and better insulins; RAGE––a multi-ligand receptor in chronic diseases; diabetes, cancer risk, and metformin––connections of metabolism and cell proliferation; prevalence of diabetes in Asia; and prioritization of care in adults with diabetes and co-existing chronic conditions.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.1111/(ISSN)1749-6632.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
This second installment of The Year in Diabetes and Obesity review series includes thought-provoking reviews on central nervous system control of glucose and energy metabolism; stearoyl CoA desaturase in obesity and metabolism; circadian disruption and metabolic dysfunction; incretin hormones; metabolic syndrome, adipokines, and dementia; interventions for the prevention or reversal of type 1 diabetes; the role of intestinal microbiome in humans and mice with type 1 diabetes; building smarter and better insulins; RAGE––a multi-ligand receptor in chronic diseases; diabetes, cancer risk, and metformin––connections of metabolism and cell proliferation; prevalence of diabetes in Asia; and prioritization of care in adults with diabetes and co-existing chronic conditions.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.1111/(ISSN)1749-6632.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
Rexford S. Ahima and Alvin C. Powers are the authors of The Year in Diabetes and Obesity, Volume 1243, published by Wiley.
Erscheint lt. Verlag | 2.3.2012 |
---|---|
Reihe/Serie | Annals of the New York Academy of Sciences |
Verlagsort | Hoboken |
Sprache | englisch |
Maße | 180 x 254 mm |
Gewicht | 309 g |
Themenwelt | Sachbuch/Ratgeber ► Gesundheit / Leben / Psychologie |
Medizinische Fachgebiete ► Innere Medizin ► Diabetologie | |
Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie | |
Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie | |
ISBN-10 | 1-57331-847-7 / 1573318477 |
ISBN-13 | 978-1-57331-847-1 / 9781573318471 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Vol. 1 & 2
Buch | Hardcover (2022)
McGraw-Hill Companies (Verlag)
229,99 €